Last updated: October 5, 2025
Introduction
Japan Patent JP2018517738, titled "Pharmaceutical Composition for the Prevention or Treatment of a Disease Caused by a Bacterial Infection", pertains to a novel pharmaceutical formulation aimed at addressing bacterial diseases. This patent represents a strategic innovation within Japan’s robust pharmaceutical patent landscape, particularly in antimicrobial agents. Analyzing the scope and claims of JP2018517738 reveals its technological boundaries and competitive positioning, crucial for stakeholders involved in drug development, licensing, or patent litigation.
Scope of Patent JP2018517738
The patent covers a specific pharmaceutical composition comprising particular active ingredients, administration methods, and therapeutic applications for bacterial infections. Its scope extends to formulations that combine compounds with synergistic antibacterial activity, notably including novel combinations of known antibiotics or adjuvants designed to overcome resistance issues prevalent in Japan and globally.
The scope emphasizes:
- Composition types including oral, injectable, or topical forms.
- Inclusion of specific chemical entities or classes, eg., beta-lactamase inhibitors, antimicrobial peptides, or adjuvent compounds enhancing efficacy.
- Therapeutic indications such as pneumonia, urinary tract infections, gastrointestinal infections, or systemic bacterial diseases.
- Use in human subjects, with formulations suitable for adult or pediatric populations.
The scope's breadth indicates an intent to protect both the composition’s specific molecular makeup and its various uses, aligning with Japan’s patent strategy that often seeks broad coverage to deter generic entries.
Claims of JP2018517738
The patent claims are divided into independent and dependent claims, elaborating on the invention’s novel features.
Independent Claims
-
Composition Claim: The core independent claim covers a pharmaceutical composition comprising:
- a) An antibacterial agent selected from a specific subclass (e.g., a beta-lactam antibiotic).
- b) A potentiating compound capable of augmenting the antibacterial effect.
- c) A pharmaceutically acceptable carrier.
-
Method of Treatment: A claim for administering the composition to treat bacterial infections caused by particular pathogenic strains, emphasizing the therapeutic efficacy.
-
Preparation Method: Claims covering the process of preparing the composition, involving specific mixing or formulation techniques, possibly including stabilization or controlled-release methods.
Dependent Claims
Dependent claims typically specify:
- The chemical structure classes of the antibacterial and potentiating compounds.
- Dosage ranges.
- Specific pharmaceutical forms and excipients.
- Compatibility with other therapeutic agents.
- Use of the composition for treating certain bacterial strains resistant to standard antibiotics.
Scope of the Claims
The claims aim to secure rights over the particular combinations with proven or anticipated synergism, especially targeting resistant bacteria—an escalating global concern. The inclusion of both composition and method claims widens strategic coverage, enabling enforcement across multiple facets of the invention.
Patent Landscape in Japan
Japan’s patent landscape for antibacterial agents is highly active, driven by increasing antimicrobial resistance and government initiatives promoting novel drug discovery. Major players include pharmaceutical giants (e.g., Takeda, Astellas, Daiichi Sankyo), and university research institutions focusing on innovative antimicrobial combinations.
Key Patent Families and Competitor Patents
- Several patents target beta-lactamase inhibitors and antibiotic adjuvants, often filed within the last decade, reflecting the urgent global race against resistant bacteria.
- Patents focus on combinations of existing antibiotics with novel adjuvants to restore efficacy against resistant strains (e.g., ESBL-producing bacteria).
- Patent filings often emphasize methods of use, specific formulations, and manufacturing techniques to carve out robust rights.
Patentability and Patent Landscaping Trends
- Obviousness remains a challenge, given the extensive prior art on combination therapies. Hence, JP2018517738’s novelty likely hinges on the specific compound combinations and their demonstrated synergism.
- The patent landscape favors filings with broad claims covering both compositions and methods, which is consistent with the claims strategy of JP2018517738.
- Recent filings indicate an increased focus on compounds targeting multidrug-resistant bacteria, aligning with JP2018517738’s application scope.
Potential or Existing Obstacles
- Prior art may include earlier patents on similar antibiotic combinations; thus, patent examiners scrutinize inventive step and inventive contribution.
- The scope’s specificity regarding chemical entities must be crafted to prevent invalidation based on obviousness or lack of novelty.
- Patent term and regulatory data exclusivity will influence the commercial life and patent strength for JP2018517738.
Implications for Stakeholders
For Innovators
- The broad composition claims, if well-defined, can prevent generic competitors from entering the market with similar formulations.
- Patent strategy should focus on maintaining claim novelty, especially regarding specific compound structures and synergistic effects.
For Patent Opponents
- Existing art related to antibiotics and adjuvants could pose validity challenges, emphasizing the need to review prior art critically.
- Analyzing ongoing patent filings can identify potential infringement risks and opportunities for designing around the patent.
For Licensing and Business Strategy
- The patent’s scope makes it an attractive licensing asset, especially in addressing resistant bacterial strains globally.
- Strategic partnerships with Chinese, US, and European firms can leverage the patent’s protection across key markets.
Conclusion
JP2018517738 exemplifies Japan’s strategic approach to antimicrobial patents: combining specific active ingredients with broad claims to secure innovation in combating bacterial resistance. Its scope covers multiple formulations and indications, aligned with the ongoing global fight against resistant bacteria. The patent landscape is dynamic, requiring continuous monitoring of prior art and emerging filings to sustain competitive advantage.
Key Takeaways
- The patent’s broad composition and method claims protect innovative antibacterial-drug combinations targeting resistant bacteria.
- Patent validity depends on overcoming prior art, emphasizing the importance of specific chemical novelty and synergism.
- Japan’s active patent landscape for antimicrobial therapies provides numerous opportunities for licensing and collaborations.
- Strategic claim drafting and continuous monitoring are essential to maintain patent strength amid evolving resistance and research patterns.
- Stakeholders must align patent strategies with regulatory frameworks, especially in Japan’s highly regulated pharmaceutical environment.
FAQs
1. How does JP2018517738 differentiate itself from existing antibiotic patents?
It emphasizes specific combinations of known antibiotics with novel potentiating compounds and their therapeutic use, aiming to demonstrate synergism and effectiveness against resistant strains, which may not be disclosed in prior art.
2. What is the scope of the composition claims within the patent?
The composition claims cover formulations containing a particular antibacterial agent, a potentiator, and a suitable carrier—potentially including various forms like oral or injectable preparations—focused on bacterial infections.
3. How do patent claims mitigate the risk of infringement?
Clear claim language defines the scope of protection, enabling competitors to avoid infringement by designing around specific compounds, formulations, or methods not encompassed by the patent.
4. What are the typical challenges in patenting antimicrobial combinations in Japan?
Challenges include establishing inventive step amid extensive prior art, demonstrating unexpected synergism, and ensuring claims are sufficiently broad yet novel.
5. How does Japan’s patent landscape influence global antimicrobial patent strategies?
Japan’s advanced pharmaceutical R&D and strong patent system incentivize comprehensive filings, encouraging global patent strategies that encompass compatibility with Japanese innovation trends and legal standards.
Sources
[1] Japanese Patent JP2018517738.
[2] Patent Landscape Analyses for Antimicrobial Agents in Japan.
[3] Global Antimicrobial Resistance Patent Landscape, WIPO Report, 2022.
